|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.997
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.985
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.980
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.949
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.914
|
Human |
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.909
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.875
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.869
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.826
|
Human |
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.824
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.773
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.753
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.746
|
Human |
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.746
|
|
|
|
regulation of hippo signaling
|
GO:0035330 |
8 |
0.745
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.737
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.727
|
Human Mouse |
|
|
cell development
|
GO:0048468 |
328 |
0.724
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.687
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.667
|
Human |
|
|
regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter
|
GO:0072366 |
1 |
0.663
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.622
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.620
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.613
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.597
|
Human |
|
|
energy reserve metabolic process
|
GO:0006112 |
22 |
0.597
|
Human |
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
47 |
0.589
|
Human |
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.580
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.577
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
22 |
0.567
|
Human |
|
|
positive regulation of glycogen biosynthetic process
|
GO:0045725 |
10 |
0.564
|
Human |
|
|
regulation of phagocytosis engulfment
|
GO:0060099 |
2 |
0.551
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.541
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.535
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.529
|
Human |
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.528
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.522
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.506
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.503
|
Human |
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.501
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.490
|
|
|
|
glucan metabolic process
|
GO:0044042 |
22 |
0.489
|
Human |
|
|
segmentation
|
GO:0035282 |
4 |
0.489
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.486
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.481
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.478
|
|
|
|
positive regulation of glucose metabolic process
|
GO:0010907 |
12 |
0.471
|
Human |
|
|
muscle structure development
|
GO:0061061 |
98 |
0.470
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.469
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.465
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.459
|
Human |
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.459
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.457
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
55 |
0.455
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.443
|
|
|
|
cell morphogenesis involved in neuron differentiation
|
GO:0048667 |
44 |
0.442
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.441
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.440
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.440
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
28 |
0.438
|
Human |
|
|
neuron projection development
|
GO:0031175 |
106 |
0.434
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.434
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.433
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.413
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.400
|
|
|
|
retina layer formation
|
GO:0010842 |
3 |
0.397
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.392
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.389
|
|
|
|
adipose tissue development
|
GO:0060612 |
2 |
0.384
|
Human |
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
27 |
0.377
|
Human |
|
|
regulation of rho gtpase activity
|
GO:0032319 |
66 |
0.369
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.365
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.350
|
Human |
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.349
|
Human |
|
|
nervous system development
|
GO:0007399 |
293 |
0.343
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.343
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.341
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.333
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.326
|
|
|
|
regulation of axonogenesis
|
GO:0050770 |
16 |
0.325
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.323
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.319
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.318
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.312
|
Human |
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.307
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.303
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.302
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.295
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.290
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.286
|
|
|
|
positive regulation of feeding behavior
|
GO:2000253 |
1 |
0.284
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.284
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.284
|
Human |
|
|
positive regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061419 |
2 |
0.283
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.282
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
42 |
0.277
|
Human |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.276
|
|
|
|
cellular polysaccharide biosynthetic process
|
GO:0033692 |
21 |
0.270
|
Human |
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.268
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.268
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.264
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.263
|
|
|
|
positive regulation of carbohydrate metabolic process
|
GO:0045913 |
21 |
0.262
|
Human |
|
|
smoothened signaling pathway
|
GO:0007224 |
14 |
0.262
|
Human |
|
|
positive regulation of cellular carbohydrate metabolic process
|
GO:0010676 |
16 |
0.253
|
Human |
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.251
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.249
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.248
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.247
|
Human |
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.246
|
Human |
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.244
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.243
|
|
|
|
myotube differentiation
|
GO:0014902 |
22 |
0.242
|
|
|
|
regulation of polysaccharide biosynthetic process
|
GO:0032885 |
20 |
0.242
|
Human |
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.241
|
Human |
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.241
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.238
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.238
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.237
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.235
|
Human |
|
|
vasculature development
|
GO:0001944 |
181 |
0.235
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.230
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.228
|
Human |
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.226
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.226
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.225
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.222
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.222
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.221
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.220
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.217
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.215
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.213
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.210
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
1 |
0.208
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.208
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
18 |
0.207
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.206
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.206
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.202
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.200
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.195
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.186
|
|
|
|
positive regulation of autophagy
|
GO:0010508 |
24 |
0.185
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.181
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.181
|
Human |
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.179
|
Human |
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.178
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.177
|
|
|
|
negative regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0071930 |
2 |
0.177
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.177
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.176
|
|
|
|
negative regulation of protein localization to nucleus
|
GO:1900181 |
34 |
0.174
|
Human |
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.172
|
|
|
|
neuron projection morphogenesis
|
GO:0048812 |
50 |
0.168
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.167
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.165
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.165
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.165
|
Human |
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.164
|
Human |
|
|
histone modification
|
GO:0016570 |
251 |
0.163
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.162
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.162
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.162
|
|
|
|
viral transcription
|
GO:0019083 |
35 |
0.160
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.156
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.152
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.152
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.152
|
Mouse Rat |
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.151
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.151
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
15 |
0.150
|
Human |
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.149
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.149
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.146
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.146
|
Human |
|
|
neurogenesis
|
GO:0022008 |
169 |
0.144
|
|
|
|
cellular carbohydrate biosynthetic process
|
GO:0034637 |
21 |
0.140
|
Human |
|
|
kidney morphogenesis
|
GO:0060993 |
19 |
0.140
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
75 |
0.139
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.137
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.136
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.135
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.135
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.134
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.132
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.132
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.131
|
Human |
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.128
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
85 |
0.127
|
Human |
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.126
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.125
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.125
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.125
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.125
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.124
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.124
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.124
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.123
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.123
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.122
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.120
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.120
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
12 |
0.113
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
157 |
0.112
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.111
|
|
|
|
blood circulation
|
GO:0008015 |
113 |
0.110
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.110
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.109
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.108
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.108
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.108
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.107
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.107
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.107
|
|
|
|
lung development
|
GO:0030324 |
20 |
0.107
|
|
|
|
negative regulation of g0 to g1 transition
|
GO:0070317 |
2 |
0.106
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
9 |
0.106
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.106
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.105
|
Human Mouse |
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.105
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.104
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.104
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.104
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.104
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.103
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.103
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.103
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.102
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.102
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.102
|
Human |
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.101
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.101
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.097
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.097
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.097
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.095
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.095
|
|
|
|
hippo signaling
|
GO:0035329 |
20 |
0.094
|
|
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
24 |
0.094
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
27 |
0.094
|
Human |
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.093
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.093
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.092
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.092
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.092
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.090
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.089
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.088
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.088
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.087
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
2 |
0.087
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.086
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.086
|
|
|
|
mating
|
GO:0007618 |
1 |
0.085
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.084
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.084
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.083
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.083
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.083
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.082
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.081
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.081
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.080
|
|
|
|
positive regulation of multi organism process
|
GO:0043902 |
56 |
0.079
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.079
|
Human |
|
|
circulatory system development
|
GO:0072359 |
262 |
0.079
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.078
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.077
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
4 |
0.077
|
|
|
|
circulatory system process
|
GO:0003013 |
113 |
0.077
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.077
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.077
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.076
|
|
|
|
macroautophagy
|
GO:0016236 |
39 |
0.076
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.076
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.075
|
|
|
|
memory
|
GO:0007613 |
3 |
0.074
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.074
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.073
|
Human |
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.072
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.072
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.072
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
14 |
0.072
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.071
|
|
|
|
endoderm development
|
GO:0007492 |
33 |
0.071
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.070
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.069
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.069
|
|
|
|
polysaccharide biosynthetic process
|
GO:0000271 |
27 |
0.069
|
Human |
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
23 |
0.069
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.068
|
Human |
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.068
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
30 |
0.068
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.068
|
Human |
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.067
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.067
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.067
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
18 |
0.066
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
84 |
0.066
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.066
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.064
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.064
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.064
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.064
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.064
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.063
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.063
|
|
|
|
negative regulation of phagocytosis engulfment
|
GO:0060101 |
1 |
0.063
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.063
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.062
|
Human |
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
10 |
0.062
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.062
|
Human |
|
|
activation of jnkk activity
|
GO:0007256 |
1 |
0.061
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
37 |
0.061
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.061
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.061
|
|
|
|
rna stabilization
|
GO:0043489 |
18 |
0.061
|
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.060
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
27 |
0.060
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.060
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
35 |
0.060
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.060
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.060
|
|
|
|
glucan biosynthetic process
|
GO:0009250 |
16 |
0.060
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.059
|
Human |
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.059
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.059
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.059
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.059
|
|
|
|
negative regulation of nfat protein import into nucleus
|
GO:0051534 |
2 |
0.058
|
Human |
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.058
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
60 |
0.058
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
3 |
0.058
|
|
|
|
cartilage development
|
GO:0051216 |
31 |
0.057
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.057
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.056
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.056
|
|
|
|
growth
|
GO:0040007 |
202 |
0.055
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.054
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.054
|
|
|
|
nfat protein import into nucleus
|
GO:0051531 |
5 |
0.054
|
Human |
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.054
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.054
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.054
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.053
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.053
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.052
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.052
|
Human |
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
38 |
0.052
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.052
|
|
|
|
negative regulation of cytoskeleton organization
|
GO:0051494 |
45 |
0.052
|
|
|
|
positive regulation of transcription by galactose
|
GO:0000411 |
1 |
0.052
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.052
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.052
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.052
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.050
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.050
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
40 |
0.050
|
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
46 |
0.050
|
Human |
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.049
|
|
|
|
regulation of mitosis
|
GO:0007088 |
63 |
0.049
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.049
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.049
|
Human |
|
|
regulation of nuclear division
|
GO:0051783 |
65 |
0.048
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.048
|
Mouse |
|
|
positive regulation of transcription initiation from rna polymerase ii promoter
|
GO:0060261 |
4 |
0.048
|
|
|
|
regulation of g0 to g1 transition
|
GO:0070316 |
2 |
0.048
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.047
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.047
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.047
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
9 |
0.047
|
|
|
|
regulation of proteasomal ubiquitin dependent protein catabolic process
|
GO:0032434 |
71 |
0.047
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.047
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.047
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.047
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
24 |
0.047
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.047
|
|
|
|
positive regulation of multicellular organism growth
|
GO:0040018 |
6 |
0.046
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.046
|
|
|
|
neuron projection extension
|
GO:1990138 |
14 |
0.046
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
3 |
0.045
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.045
|
|
|
|
regionalization
|
GO:0003002 |
29 |
0.045
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.044
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.044
|
Human |
|
|
regulation of rac gtpase activity
|
GO:0032314 |
4 |
0.044
|
|
|
|
multi organism metabolic process
|
GO:0044033 |
41 |
0.044
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.043
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
54 |
0.043
|
Human |
|
|
regulation of lipid kinase activity
|
GO:0043550 |
19 |
0.043
|
|
|
|
positive regulation of developmental growth
|
GO:0048639 |
16 |
0.043
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.043
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.043
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.043
|
Human |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.043
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.043
|
|
|
|
regulation of system process
|
GO:0044057 |
101 |
0.043
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.042
|
|
|
|
regulation of cell size
|
GO:0008361 |
19 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.042
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.042
|
|
|
|
regulation of dendrite morphogenesis
|
GO:0048814 |
11 |
0.042
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.041
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.041
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.040
|
Human |
|
|
hormone transport
|
GO:0009914 |
68 |
0.040
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.040
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.040
|
|
|
|
negative regulation of nucleocytoplasmic transport
|
GO:0046823 |
37 |
0.040
|
Human |
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.039
|
|
|
|
positive regulation of gluconeogenesis
|
GO:0045722 |
1 |
0.039
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.038
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.038
|
|
|
|
post embryonic organ development
|
GO:0048569 |
1 |
0.038
|
|
|
|
developmental cell growth
|
GO:0048588 |
18 |
0.038
|
|
|
|
nephron development
|
GO:0072006 |
30 |
0.038
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.037
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
1 |
0.037
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.037
|
|
|
|
regulation of rna stability
|
GO:0043487 |
23 |
0.037
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
2 |
0.037
|
|
|
|
pigmentation
|
GO:0043473 |
22 |
0.037
|
|
|
|
regulation of stress activated protein kinase signaling cascade
|
GO:0070302 |
85 |
0.037
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.037
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.036
|
|
|
|
translation
|
GO:0006412 |
132 |
0.036
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
22 |
0.036
|
Human |
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
18 |
0.036
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.035
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.035
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.035
|
|
|
|
regulation of growth rate
|
GO:0040009 |
1 |
0.034
|
|
|
|
hair cell differentiation
|
GO:0035315 |
2 |
0.034
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.034
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
59 |
0.034
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
8 |
0.034
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.034
|
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.033
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.033
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.033
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
17 |
0.033
|
|
|
|
positive regulation of hormone biosynthetic process
|
GO:0046886 |
4 |
0.033
|
|
|
|
positive regulation of glycogen metabolic process
|
GO:0070875 |
10 |
0.033
|
Human |
|
|
protein deacetylation
|
GO:0006476 |
38 |
0.032
|
Mouse |
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.032
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
2 |
0.032
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.032
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.032
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.032
|
Human |
|
|
regulation of multicellular organism growth
|
GO:0040014 |
8 |
0.032
|
|
|
|
regulation of dendrite development
|
GO:0050773 |
18 |
0.032
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.032
|
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.031
|
|
|
|
single organism behavior
|
GO:0044708 |
28 |
0.031
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.031
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.031
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.031
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.031
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
2 |
0.031
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.030
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.030
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.030
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
9 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.030
|
Mouse |
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
35 |
0.030
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
3 |
0.030
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.029
|
Mouse |
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.029
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.029
|
|
|
|
dendrite development
|
GO:0016358 |
24 |
0.029
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.028
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.028
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.028
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.028
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.028
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.028
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.028
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.028
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.028
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.028
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.027
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.027
|
|
|
|
microtubule based movement
|
GO:0007018 |
32 |
0.027
|
|
